Finance

Lists
Outlook: 56.2% bullish·0.0% bearish
Go to analysis
PRGO:NYSE
Perrigo Company PLC
$16.72
-1.36%
(-0.23) 1D
Nov 10, 1:03:20 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRGO...
Open
$16.67
High
$16.79
Low
$16.21
Mkt. cap
2.32B
Avg. vol.
2.52M
Volume
545.09K
Dividend
6.94%
Quarterly dividend
$0.29
Ex-dividend date
Aug 28, 2026
52-wk high
$17.02
52-wk low
$9.22
EPS
-$12.84
Beta
0.70
Shares outstanding
138.80M
No. of employees
8K
Open
$16.67
High
$16.79
Low
$16.21
Mkt. cap
2.32B
Avg. vol.
2.52M
Volume
545.09K
Dividend
6.94%
Quarterly dividend
$0.29
Ex-dividend date
Aug 28, 2026
52-wk high
$17.02
52-wk low
$9.22
EPS
-$12.84
Beta
0.70
Shares outstanding
138.80M
No. of employees
8K
News stories
From web sources and news partners
Profile
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
About Perrigo Company PLC
CEOMurray S. Kessler
Employees8.1K
Founded1887
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteperrigo.com
Analyst ratings
Based on 2 analysts giving stock ratings to PRGO in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PRGO in the last 3 months.
Highest
Current $16.72
$19.00 (+13.64%)
Average
$17.00 (+1.67%)
Lowest
$15.00 (-10.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Susan Anderson
Canaccord Genuity
Buy
Reiterated
$19.00
+13.6%
11/05/2026
Chris Schott
J.P. Morgan
Hold
Maintained
$15.00
-10.3%
10/21/2026
Christine Dooley
Argus Research
Hold
Maintained
-
-
05/19/2026
Keith Devas
Jefferies
Hold
Maintained
$23.00
+37.6%
10/27/2025
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$0.60 / $0.53
+12.40%beat
Revenue / Est. (USD)
988.60M / 995.90M
-0.73%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.11B
969.20M
1.02B
988.60M
Cost of goods sold
747.40M
643.70M
708.90M
665.30M
Cost of revenue
747.40M
643.70M
708.90M
665.30M
Research and development expenses
21.80M
24.60M
23.70M
21.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
255.60M
267.30M
251.20M
271.70M
Operating expense
249.00M
291.90M
274.60M
293.50M
Total operating expenses
996.40M
935.60M
983.50M
958.80M
Operating income
113.20M
33.60M
39.30M
29.80M
Other non operating income
-10.70M
3.70M
10.10M
-800.00K
EBT including unusual items
-1.33B
-408.60M
105.50M
-18.10M
EBT excluding unusual items
68.70M
-1.30M
-8.50M
-11.50M
Income tax expense
82.90M
-18.70M
16.90M
-3.80M
Effective tax rate
-6.23%
4.58%
16.02%
20.99%
Other operating expenses
-28.40M
-
-300.00K
-100.00K
Net income
-1.42B
-398.60M
74.50M
-27.50M
Net profit margin
-127.80%
-41.13%
7.28%
-2.78%
Earnings per share
0.77
0.43
0.50
0.60
Interest and investment income
-
-
-
-
Interest expense
-52.80M
-49.00M
-47.00M
-46.50M
Net interest expenses
-52.80M
-49.00M
-47.00M
-46.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
199.10M
116.90M
116.20M
109.30M
Gain or loss from assets sale
-
-
-129.50M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps